Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Clinical Nuclear Medicine|June 5, 2025
The Characteristics of Prostate Mucinous Adenocarcinoma Visualized by 68 Ga-PSMA, 68 Ga-FAPI, and 18 F-FDG PET/CTZhuxu Sun, Xi Jiang, Guangbo Fu, et al.International Urology and Nephrology|May 4, 2019
MR urethrography versus X-ray urethrography compared with operative findings for the evaluation of urethral stricturesWeijing Tao, Genji Bai, Guangbo Fu, et al.Diagnostic Pathology|July 25, 2020
SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case reportZhongying Guo, Xiaobing Niu, Guangbo Fu, et al.Carcinogenesis|August 8, 2008
Genetic variants in RUNX3 and risk of bladder cancer: a haplotype-based analysisZhizhong Zhang, Shizhi Wang, Meilin Wang, et al.Mutation Research|December 17, 2008
Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancerMeilin Wang, Miaomiao Wang, Gong Cheng, et al.DNA and Cell Biology|March 12, 2010
Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancerMeilin Wang, Chao Qin, Jian Zhu, et al.Carcinogenesis|April 17, 2009
Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese populationMeilin Wang, Miaomiao Wang, Wei Zhang, et al.Aging|August 7, 2020
Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathwayHengbing Wang, Xiaobing Niu, Hesong Jiang, et al.Oncotargets and Therapy|November 5, 2020
Hsa_circRNA_100146 Acts as a Sponge of miR-149-5p in Promoting Bladder Cancer Progression via Regulating RNF2Hengbing Wang, Xiaobing Niu, Fei Mao, et al.Oncology Letters|January 27, 2017
miR-143 inhibits bladder cancer cell proliferation and enhances their sensitivity to gemcitabine by repressing IGF-1R signalingHengbing Wang, Qi Li, Xiaobing Niu, et al.Pageof 4